Pieris Pharmaceuticals Ownership 2024 | Who Owns Pieris Pharmaceuticals Now?
Institutional Ownership
38.15%
Insider Ownership
6.97%
Retail Ownership
54.88%
Institutional Holders
40.00
Pieris Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -1,989 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -10,280 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -6,145 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -5,573 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -243,592 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -222,819 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -907,390 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -5,006 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -22,638 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -6,856 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -962,358 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -25,700 | -100.00% | - | Jun 30, 2024 |
| COMMERCE BANK | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -1,429,588 | -100.00% | - | Jun 30, 2024 |
| BVF INC/IL | - | - | - | -20,609,863 | -100.00% | - | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -220,800 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -772,784 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -211,745 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -1,037,639 | -100.00% | - | Jun 30, 2024 |
Pieris Pharmaceuticals's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -1,989 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -10,280 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -6,145 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -5,573 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -243,592 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -222,819 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -907,390 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -5,006 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -22,638 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -6,856 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -962,358 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -25,700 | -100.00% | - | Jun 30, 2024 |
| COMMERCE BANK | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -1,429,588 | -100.00% | - | Jun 30, 2024 |
| BVF INC/IL | - | - | - | -20,609,863 | -100.00% | - | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -220,800 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -772,784 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -211,745 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -1,037,639 | -100.00% | - | Jun 30, 2024 |
The largest Pieris Pharmaceuticals shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of Pieris Pharmaceuticals (PIRS), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALLWORTH FINANCIAL LP | - | - | - | -350 | -100.00% | - | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -516 | -100.00% | - | Jun 30, 2024 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -1,120 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -1,989 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -5,006 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -5,573 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -6,145 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -6,856 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -10,280 | -100.00% | - | Jun 30, 2024 |
| CERITY PARTNERS LLC | - | - | - | -10,300 | -100.00% | - | Jun 30, 2024 |
| KESTRA ADVISORY SERVICES, LLC | - | - | - | -17,500 | -100.00% | - | Jun 30, 2024 |
| COMMERCE BANK | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -20,756 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -22,638 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -25,700 | -100.00% | - | Jun 30, 2024 |
| NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -42,742 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -51,994 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -58,265 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Pieris Pharmaceuticals's largest institutional buyer is ALLWORTH FINANCIAL LP. The company purchased -0.35K stocks of PIRS, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | - | - | - | -20,609,863 | -100.00% | - | Jun 30, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | - | - | - | -8,779,162 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -1,429,588 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -1,037,639 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -962,358 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -907,390 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -772,784 | -100.00% | - | Jun 30, 2024 |
| CM MANAGEMENT, LLC | - | - | - | -575,000 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -243,592 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -222,819 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -220,800 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -211,745 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -145,833 | -100.00% | - | Jun 30, 2024 |
| SUMMIT TRAIL ADVISORS, LLC | - | - | - | -140,000 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -58,265 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -51,994 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -42,742 | -100.00% | - | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -25,700 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Pieris Pharmaceuticals's biggest institutional seller is BVF INC/IL. The company sold -20.61M shares of PIRS, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | - | - | - | -20,609,863 | -100.00% | - | Jun 30, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | - | - | - | -8,779,162 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -1,429,588 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -1,037,639 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -962,358 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -907,390 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -772,784 | -100.00% | - | Jun 30, 2024 |
| CM MANAGEMENT, LLC | - | - | - | -575,000 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -243,592 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -222,819 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -220,800 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -211,745 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -145,833 | -100.00% | - | Jun 30, 2024 |
| SUMMIT TRAIL ADVISORS, LLC | - | - | - | -140,000 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -58,265 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -51,994 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -42,742 | -100.00% | - | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -25,700 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -22,638 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -20,756 | -100.00% | - | Jun 30, 2024 |
| COMMERCE BANK | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| KESTRA ADVISORY SERVICES, LLC | - | - | - | -17,500 | -100.00% | - | Jun 30, 2024 |
| CERITY PARTNERS LLC | - | - | - | -10,300 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -10,280 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -6,856 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -6,145 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -5,573 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -5,006 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -1,989 | -100.00% | - | Jun 30, 2024 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -1,120 | -100.00% | - | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -516 | -100.00% | - | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | - | - | - | -350 | -100.00% | - | Jun 30, 2024 |
Pieris Pharmaceuticals's largest sold out institutional shareholder by shares sold is BVF INC/IL, sold -20.61M shares, valued at -, as of undefined.
Pieris Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| TEKLA HEALTHCARE INVESTORS | 0.80% | 685,834 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.64% | 302,489 | - | - | Mar 31, 2024 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.48% | 34,753 | - | - | Sep 30, 2022 |
| Tekla Healthcare Opportunities Fund | 0.10% | 221,758 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.05% | 116,500 | - | - | Mar 28, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.02% | 3,495 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 8,549 | - | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.01% | 1,112,083 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 75,974 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 81,145 | - | - | Aug 31, 2023 |
| Federated Hermes MDT Series | 0.01% | 15,932 | - | - | Jan 31, 2024 |
| PFM Multi-Manager Series Trust | 0.01% | 4,360 | - | - | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 722,472 | 7,564 | 1.06% | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 16,596 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 140,951 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 885,502 | -885,502 | -50.00% | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 8,336 | - | - | Mar 28, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 7,116 | - | - | Mar 31, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 26,480 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 14,532 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,015 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 35,732 | - | - | Feb 29, 2024 |
| SunAmerica Specialty Series | 0.00% | 409 | - | - | Apr 30, 2021 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 24,798 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 7,557 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 2,855 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 38,277 | - | - | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 18,161 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 34,600 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 529 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 26,815 | - | - | Mar 28, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 14,916 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 9,300 | - | - | Mar 31, 2024 |
| PGIM ETF TRUST | 0.00% | 8,522 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 1,151 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 13,524 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 25,192 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 169,502 | - | - | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 6,677 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 9,307 | - | - | Mar 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 300 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 246,450 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 64,639 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 16,965 | - | - | Jan 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 4,136 | - | - | Jan 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 15,212 | - | - | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,300 | - | - | Mar 28, 2024 |
| Voya MUTUAL FUNDS | 0.00% | 7,207 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 9,559 | - | - | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 3,285 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 98,087 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 24,572 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 26,869 | - | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 539 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 62,273 | - | - | Dec 31, 2023 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 52,400 | - | - | Mar 31, 2024 |
| iShares U.S. ETF Trust | 0.00% | 1,408 | - | - | Jan 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 4,749 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 11,323 | - | - | Mar 31, 2024 |
| MFS SERIES TRUST X | 0.00% | 69,637 | - | - | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 6,493 | - | - | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 22,404 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 19,192 | - | - | Mar 31, 2024 |
| Legg Mason Global Asset Management Trust | 0.00% | 29,063 | - | - | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 10,418 | - | - | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 6,594 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 488 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 1,728 | - | - | Mar 31, 2024 |
| John Hancock Funds II | 0.00% | 9,354 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 4,255 | - | - | Mar 28, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 12,800 | - | - | Feb 29, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 29 | - | - | Jan 31, 2024 |
Pieris Pharmaceuticals's largest mutual fund holder by % of total assets is "TEKLA HEALTHCARE INVESTORS", owning 685.83K shares, compromising 0.80% of its total assets.
Pieris Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 40 | -13.04% |
| 31 Dec, 23 | 46 | 4.55% |
| 30 Sep, 23 | 44 | -8.33% |
| 30 Jun, 23 | 48 | -22.58% |
| 31 Mar, 23 | 62 | -3.13% |
| 31 Dec, 22 | 64 | 1.59% |
| 30 Sep, 22 | 63 | -7.35% |
| 30 Jun, 22 | 68 | -10.53% |
| 31 Mar, 22 | 76 | -9.52% |
| 31 Dec, 21 | 84 | -2.33% |
| 30 Sep, 21 | 86 | 1.18% |
| 30 Jun, 21 | 85 | 4.94% |
| 31 Mar, 21 | 81 | -2.41% |
| 31 Dec, 20 | 83 | -7.78% |
| 30 Sep, 20 | 90 | -3.23% |
| 30 Jun, 20 | 93 | -1.06% |
| 31 Mar, 20 | 94 | -6.00% |
| 31 Dec, 19 | 100 | -1.96% |
| 30 Sep, 19 | 102 | 10.87% |
| 30 Jun, 19 | 92 | 1.10% |
| 31 Mar, 19 | 91 | -7.14% |
| 31 Dec, 18 | 98 | -6.67% |
| 30 Sep, 18 | 105 | -8.70% |
| 30 Jun, 18 | 115 | -1.71% |
| 31 Mar, 18 | 117 | 28.57% |
| 31 Dec, 17 | 91 | 35.82% |
| 30 Sep, 17 | 67 | 39.58% |
| 30 Jun, 17 | 48 | 77.78% |
| 31 Mar, 17 | 27 | 12.50% |
| 31 Dec, 16 | 24 | -17.24% |
| 30 Sep, 16 | 29 | 11.54% |
| 30 Jun, 16 | 26 | 62.50% |
| 31 Mar, 16 | 16 | -11.11% |
| 31 Dec, 15 | 18 | 38.46% |
| 30 Sep, 15 | 13 | - |
| 30 Jun, 15 | 13 | - |
As of 31 Mar 24, 40 institutions are holding Pieris Pharmaceuticals's shares, representing a decrease of -13.04% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 37,747,023 | -2.00% |
| 31 Dec, 23 | 38,517,239 | -4.57% |
| 30 Sep, 23 | 40,359,937 | -16.98% |
| 30 Jun, 23 | 48,613,344 | 41.95% |
| 31 Mar, 23 | 34,247,524 | -3.28% |
| 31 Dec, 22 | 35,408,934 | 1.49% |
| 30 Sep, 22 | 34,889,090 | -6.59% |
| 30 Jun, 22 | 37,349,747 | -1.54% |
| 31 Mar, 22 | 37,935,793 | 5.75% |
| 31 Dec, 21 | 35,872,993 | 12.70% |
| 30 Sep, 21 | 31,830,739 | 19.45% |
| 30 Jun, 21 | 26,648,849 | -16.94% |
| 31 Mar, 21 | 32,083,520 | -3.72% |
| 31 Dec, 20 | 33,322,985 | 0.63% |
| 30 Sep, 20 | 33,113,370 | -3.51% |
| 30 Jun, 20 | 34,317,386 | -6.59% |
| 31 Mar, 20 | 36,738,816 | 3.81% |
| 31 Dec, 19 | 35,390,234 | 25.29% |
| 30 Sep, 19 | 28,247,298 | 3.79% |
| 30 Jun, 19 | 27,216,678 | -7.25% |
| 31 Mar, 19 | 29,343,810 | -15.59% |
| 31 Dec, 18 | 34,764,499 | -1.81% |
| 30 Sep, 18 | 35,406,022 | 0.90% |
| 30 Jun, 18 | 35,090,201 | 3.02% |
| 31 Mar, 18 | 34,061,056 | 43.73% |
| 31 Dec, 17 | 23,698,537 | 4.88% |
| 30 Sep, 17 | 22,595,587 | 0.37% |
| 30 Jun, 17 | 22,512,980 | 15.95% |
| 31 Mar, 17 | 19,415,637 | -3.70% |
| 31 Dec, 16 | 20,162,440 | -1.52% |
| 30 Sep, 16 | 20,474,081 | 3.87% |
| 30 Jun, 16 | 19,712,020 | 13.19% |
| 31 Mar, 16 | 17,415,286 | -1.55% |
| 31 Dec, 15 | 17,690,231 | -4.28% |
| 30 Sep, 15 | 18,480,416 | 9.09% |
| 30 Jun, 15 | 16,940,081 | - |
Pieris Pharmaceuticals (PIRS) has 37.75M shares outstanding as of 31 Mar 24, down -2.00% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 38.15% | 2.51% |
| 31 Dec, 23 | 38.96% | 1.84% |
| 30 Sep, 23 | 46.05% | 1.08% |
| 30 Jun, 23 | 65.24% | 3.09% |
| 31 Mar, 23 | 45.96% | 2.02% |
| 31 Dec, 22 | 47.74% | 2.17% |
| 30 Sep, 22 | 46.90% | 1.85% |
| 30 Jun, 22 | 50.39% | 1.90% |
| 31 Mar, 22 | 51.47% | 1.67% |
| 31 Dec, 21 | 55.58% | 2.52% |
| 30 Sep, 21 | 47.00% | 2.54% |
| 30 Jun, 21 | 43.05% | 1.33% |
| 31 Mar, 21 | 56.99% | 1.52% |
| 31 Dec, 20 | 61.16% | 1.65% |
| 30 Sep, 20 | 60.94% | 1.42% |
| 30 Jun, 20 | 65.53% | 1.48% |
| 31 Mar, 20 | 66.54% | 1.36% |
| 31 Dec, 19 | 69.91% | 2.13% |
| 30 Sep, 19 | 57.24% | 1.87% |
| 30 Jun, 19 | 55.31% | 1.66% |
| 31 Mar, 19 | 57.68% | 1.34% |
| 31 Dec, 18 | 65.49% | 1.53% |
| 30 Sep, 18 | 65.46% | 1.55% |
| 30 Jun, 18 | 65.00% | 1.40% |
| 31 Mar, 18 | 68.06% | 3.04% |
| 31 Dec, 17 | 47.35% | 1.83% |
| 30 Sep, 17 | 50.91% | 1.89% |
| 30 Jun, 17 | 51.86% | 2.55% |
| 31 Mar, 17 | 45.09% | 1.93% |
| 31 Dec, 16 | 48.34% | 2.14% |
| 30 Sep, 16 | 47.54% | 2.04% |
| 30 Jun, 16 | 48.24% | 2.52% |
| 31 Mar, 16 | 43.72% | 2.21% |
| 31 Dec, 15 | 44.46% | 1.97% |
| 30 Sep, 15 | 47.52% | 1.43% |
| 30 Jun, 15 | 57.56% | - |
As of 31 Mar 24, Pieris Pharmaceuticals is held by 38.15% institutional shareholders, representing a 2.51% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 15 | 15.38% |
| 31 Dec, 23 | 13 | -27.78% |
| 30 Sep, 23 | 18 | 38.46% |
| 30 Jun, 23 | 13 | -31.58% |
| 31 Mar, 23 | 19 | -9.52% |
| 31 Dec, 22 | 21 | 16.67% |
| 30 Sep, 22 | 18 | -28.00% |
| 30 Jun, 22 | 25 | -30.56% |
| 31 Mar, 22 | 36 | -12.20% |
| 31 Dec, 21 | 41 | 7.89% |
| 30 Sep, 21 | 38 | 5.56% |
| 30 Jun, 21 | 36 | 28.57% |
| 31 Mar, 21 | 28 | -22.22% |
| 31 Dec, 20 | 36 | 12.50% |
| 30 Sep, 20 | 32 | -27.27% |
| 30 Jun, 20 | 44 | -4.35% |
| 31 Mar, 20 | 46 | -11.54% |
| 31 Dec, 19 | 52 | 8.33% |
| 30 Sep, 19 | 48 | 23.08% |
| 30 Jun, 19 | 39 | 34.48% |
| 31 Mar, 19 | 29 | -43.14% |
| 31 Dec, 18 | 51 | 2.00% |
| 30 Sep, 18 | 50 | -21.88% |
| 30 Jun, 18 | 64 | -27.27% |
| 31 Mar, 18 | 88 | 54.39% |
| 31 Dec, 17 | 57 | 35.71% |
| 30 Sep, 17 | 42 | 13.51% |
| 30 Jun, 17 | 37 | 131.25% |
| 31 Mar, 17 | 16 | 77.78% |
| 31 Dec, 16 | 9 | -40.00% |
| 30 Sep, 16 | 15 | - |
| 30 Jun, 16 | 15 | 87.50% |
| 31 Mar, 16 | 8 | -11.11% |
| 31 Dec, 15 | 9 | - |
| 30 Sep, 15 | 9 | -30.77% |
| 30 Jun, 15 | 13 | - |
15 institutional shareholders have increased their position in PIRS stock as of 31 Mar 24 compared to 13 in the previous quarter (a 15.38% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 6 | -33.33% |
| 31 Dec, 23 | 9 | 125.00% |
| 30 Sep, 23 | 4 | -76.47% |
| 30 Jun, 23 | 17 | -10.53% |
| 31 Mar, 23 | 19 | -13.64% |
| 31 Dec, 22 | 22 | 4.76% |
| 30 Sep, 22 | 21 | -16.00% |
| 30 Jun, 22 | 25 | 38.89% |
| 31 Mar, 22 | 18 | -14.29% |
| 31 Dec, 21 | 21 | 10.53% |
| 30 Sep, 21 | 19 | -36.67% |
| 30 Jun, 21 | 30 | 3.45% |
| 31 Mar, 21 | 29 | 38.10% |
| 31 Dec, 20 | 21 | -38.24% |
| 30 Sep, 20 | 34 | 36.00% |
| 30 Jun, 20 | 25 | -19.35% |
| 31 Mar, 20 | 31 | - |
| 31 Dec, 19 | 31 | 3.33% |
| 30 Sep, 19 | 30 | -11.76% |
| 30 Jun, 19 | 34 | 13.33% |
| 31 Mar, 19 | 30 | 7.14% |
| 31 Dec, 18 | 28 | -6.67% |
| 30 Sep, 18 | 30 | 7.14% |
| 30 Jun, 18 | 28 | 154.55% |
| 31 Mar, 18 | 11 | -31.25% |
| 31 Dec, 17 | 16 | 60.00% |
| 30 Sep, 17 | 10 | 25.00% |
| 30 Jun, 17 | 8 | 100.00% |
| 31 Mar, 17 | 4 | 33.33% |
| 31 Dec, 16 | 3 | -25.00% |
| 30 Sep, 16 | 4 | -20.00% |
| 30 Jun, 16 | 5 | 150.00% |
| 31 Mar, 16 | 2 | -50.00% |
| 31 Dec, 15 | 4 | 300.00% |
| 30 Sep, 15 | 1 | - |
| 30 Jun, 15 | - | - |
6 institutional shareholders have reduced their position in PIRS stock as of 31 Mar 24 compared to 9 in the previous quarter (a -33.33% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 40 | -13.04% | 37,747,023 | -2.00% | 38.15% | 2.51% | 15 | 15.38% | 6 | -33.33% |
| 31 Dec, 23 | 46 | 4.55% | 38,517,239 | -4.57% | 38.96% | 1.84% | 13 | -27.78% | 9 | 125.00% |
| 30 Sep, 23 | 44 | -8.33% | 40,359,937 | -16.98% | 46.05% | 1.08% | 18 | 38.46% | 4 | -76.47% |
| 30 Jun, 23 | 48 | -22.58% | 48,613,344 | 41.95% | 65.24% | 3.09% | 13 | -31.58% | 17 | -10.53% |
| 31 Mar, 23 | 62 | -3.13% | 34,247,524 | -3.28% | 45.96% | 2.02% | 19 | -9.52% | 19 | -13.64% |
| 31 Dec, 22 | 64 | 1.59% | 35,408,934 | 1.49% | 47.74% | 2.17% | 21 | 16.67% | 22 | 4.76% |
| 30 Sep, 22 | 63 | -7.35% | 34,889,090 | -6.59% | 46.90% | 1.85% | 18 | -28.00% | 21 | -16.00% |
| 30 Jun, 22 | 68 | -10.53% | 37,349,747 | -1.54% | 50.39% | 1.90% | 25 | -30.56% | 25 | 38.89% |
| 31 Mar, 22 | 76 | -9.52% | 37,935,793 | 5.75% | 51.47% | 1.67% | 36 | -12.20% | 18 | -14.29% |
| 31 Dec, 21 | 84 | -2.33% | 35,872,993 | 12.70% | 55.58% | 2.52% | 41 | 7.89% | 21 | 10.53% |
| 30 Sep, 21 | 86 | 1.18% | 31,830,739 | 19.45% | 47.00% | 2.54% | 38 | 5.56% | 19 | -36.67% |
| 30 Jun, 21 | 85 | 4.94% | 26,648,849 | -16.94% | 43.05% | 1.33% | 36 | 28.57% | 30 | 3.45% |
| 31 Mar, 21 | 81 | -2.41% | 32,083,520 | -3.72% | 56.99% | 1.52% | 28 | -22.22% | 29 | 38.10% |
| 31 Dec, 20 | 83 | -7.78% | 33,322,985 | 0.63% | 61.16% | 1.65% | 36 | 12.50% | 21 | -38.24% |
| 30 Sep, 20 | 90 | -3.23% | 33,113,370 | -3.51% | 60.94% | 1.42% | 32 | -27.27% | 34 | 36.00% |
| 30 Jun, 20 | 93 | -1.06% | 34,317,386 | -6.59% | 65.53% | 1.48% | 44 | -4.35% | 25 | -19.35% |
| 31 Mar, 20 | 94 | -6.00% | 36,738,816 | 3.81% | 66.54% | 1.36% | 46 | -11.54% | 31 | - |
| 31 Dec, 19 | 100 | -1.96% | 35,390,234 | 25.29% | 69.91% | 2.13% | 52 | 8.33% | 31 | 3.33% |
| 30 Sep, 19 | 102 | 10.87% | 28,247,298 | 3.79% | 57.24% | 1.87% | 48 | 23.08% | 30 | -11.76% |
| 30 Jun, 19 | 92 | 1.10% | 27,216,678 | -7.25% | 55.31% | 1.66% | 39 | 34.48% | 34 | 13.33% |
| 31 Mar, 19 | 91 | -7.14% | 29,343,810 | -15.59% | 57.68% | 1.34% | 29 | -43.14% | 30 | 7.14% |
| 31 Dec, 18 | 98 | -6.67% | 34,764,499 | -1.81% | 65.49% | 1.53% | 51 | 2.00% | 28 | -6.67% |
| 30 Sep, 18 | 105 | -8.70% | 35,406,022 | 0.90% | 65.46% | 1.55% | 50 | -21.88% | 30 | 7.14% |
| 30 Jun, 18 | 115 | -1.71% | 35,090,201 | 3.02% | 65.00% | 1.40% | 64 | -27.27% | 28 | 154.55% |
| 31 Mar, 18 | 117 | 28.57% | 34,061,056 | 43.73% | 68.06% | 3.04% | 88 | 54.39% | 11 | -31.25% |
| 31 Dec, 17 | 91 | 35.82% | 23,698,537 | 4.88% | 47.35% | 1.83% | 57 | 35.71% | 16 | 60.00% |
| 30 Sep, 17 | 67 | 39.58% | 22,595,587 | 0.37% | 50.91% | 1.89% | 42 | 13.51% | 10 | 25.00% |
| 30 Jun, 17 | 48 | 77.78% | 22,512,980 | 15.95% | 51.86% | 2.55% | 37 | 131.25% | 8 | 100.00% |
| 31 Mar, 17 | 27 | 12.50% | 19,415,637 | -3.70% | 45.09% | 1.93% | 16 | 77.78% | 4 | 33.33% |
| 31 Dec, 16 | 24 | -17.24% | 20,162,440 | -1.52% | 48.34% | 2.14% | 9 | -40.00% | 3 | -25.00% |
| 30 Sep, 16 | 29 | 11.54% | 20,474,081 | 3.87% | 47.54% | 2.04% | 15 | - | 4 | -20.00% |
| 30 Jun, 16 | 26 | 62.50% | 19,712,020 | 13.19% | 48.24% | 2.52% | 15 | 87.50% | 5 | 150.00% |
| 31 Mar, 16 | 16 | -11.11% | 17,415,286 | -1.55% | 43.72% | 2.21% | 8 | -11.11% | 2 | -50.00% |
| 31 Dec, 15 | 18 | 38.46% | 17,690,231 | -4.28% | 44.46% | 1.97% | 9 | - | 4 | 300.00% |
| 30 Sep, 15 | 13 | - | 18,480,416 | 9.09% | 47.52% | 1.43% | 9 | -30.77% | 1 | - |
| 30 Jun, 15 | 13 | - | 16,940,081 | - | 57.56% | - | 13 | - | - | - |
Pieris Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Pieris Pharmaceuticals's stock was made by BVF PARTNERS L P/IL on May 22 2023, selling - shares at - per share (valued at -). The last insider buy of PIRS was made by ADAR1 Capital Management, LLC on Aug 12 2024, buying 2,243 shares at $15.88 per share (worth $35.62K).
Pieris Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 3 | - | - |
| Q2 2023 | 8 | 9 | 88.89% |
| Q1 2023 | 5 | - | - |
| Q2 2022 | 12 | - | - |
| Q1 2022 | 6 | - | - |
| Q4 2021 | - | 6 | - |
| Q3 2021 | 2 | 11 | 18.18% |
| Q2 2021 | 7 | - | - |
| Q1 2021 | 3 | - | - |
| Q3 2020 | - | 1 | - |
| Q2 2020 | 9 | - | - |
| Q1 2020 | 12 | - | - |
| Q4 2019 | 1 | - | - |
| Q3 2019 | 3 | 13 | 23.08% |
| Q2 2019 | 1 | - | - |
| Q1 2019 | 15 | 3 | 500.00% |
| Q4 2018 | 3 | 6 | 50.00% |
| Q3 2018 | 2 | - | - |
| Q2 2018 | 3 | 2 | 150.00% |
| Q1 2018 | 15 | 6 | 250.00% |
3 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Pieris Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 3 | - | - |
| Q2 2023 | 1 | - | - |
| Q1 2023 | - | - | - |
| Q2 2022 | 1 | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | 2 | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q3 2020 | - | 1 | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | - | 3 | - |
| Q2 2019 | - | - | - |
| Q1 2019 | - | - | - |
| Q4 2018 | - | - | - |
| Q3 2018 | 1 | - | - |
| Q2 2018 | 1 | 2 | 50.00% |
| Q1 2018 | - | 4 | - |
As of Q3 2024, Insider owners conducted 3 open market buy trades and 0 open market sell trades of Pieris Pharmaceuticals's stocks.
Pieris Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| CKPT | Checkpoint Therapeutics, Inc. |
| CUE | Cue Biopharma, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| ACHL | Achilles Therapeutics plc |
| MREO | Mereo BioPharma Group plc |
| ADCT | ADC Therapeutics SA |
| PDSB | PDS Biotechnology Corporation |
| ADAP | Adaptimmune Therapeutics plc |
| CRVS | Corvus Pharmaceuticals, Inc. |
| MDNA | Medicenna Therapeutics Corp. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| AGEN | Agenus Inc. |
| AFMD | Affimed N.V. |
| LPTX | Leap Therapeutics, Inc. |
PIRS Ownership FAQ
Who Owns Pieris Pharmaceuticals?
Pieris Pharmaceuticals is owned by institutional shareholders (38.15%), insiders (6.97%), and public (54.88%). The largest institutional shareholder of Pieris Pharmaceuticals is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is TEKLA HEALTHCARE INVESTORS (0.80% of total shares).
Who are the major institutional shareholders of Pieris Pharmaceuticals?
Pieris Pharmaceuticals's major institutional shareholders are JPMORGAN CHASE & CO, US BANCORP \DE\, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, and NORTHERN TRUST CORP. The top five shareholders own together 0% of the company's share outstanding.
How many Pieris Pharmaceuticals shareholders are there?
As of Mar 2024, there are 40 institutional shareholders of Pieris Pharmaceuticals.
What percentage of Pieris Pharmaceuticals is owned by JPMORGAN CHASE & CO?
JPMORGAN CHASE & CO owns 0 shares of Pieris Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).
What percentage of Pieris Pharmaceuticals is owned by US BANCORP \DE\?
As of Jun 2024, US BANCORP \DE\ holds 0 shares of Pieris Pharmaceuticals (PIRS), compromising 0% of the company, valued at $0.
What percentage of Pieris Pharmaceuticals is owned by BANK OF AMERICA CORP /DE/?
BANK OF AMERICA CORP /DE/ is the third largest holder of Pieris Pharmaceuticals. The company owns 0 of the company's shares outstanding (worth $0).